Top Investments: NCI Building Systems (NYSE:NCS), Nutraceutical International Corporation (NASDAQ:NUTR), PMC-Sierra (NASDAQ:PMCS), Emmis Communications Corp. (NASDAQ:EMMS), Aeterna Zentaris (NASDAQ:AEZS)

NCI Building Systems Inc. (NYSE:NCS) shares advanced 0.48% in last trading session and ended the day at $10.43. NCS Gross Margin is 22.30% and its has a return on assets of 1.40%. NCI Building Systems Inc. (NYSE:NCS) quarterly performance is -28.37%.

NCI Building Systems, Inc. is a manufacturer and marketer of metal products for the nonresidential construction industry. The Company provides metal coil coating services for commercial and construction applications, servicing customers. The Company design, engineers, manufactures and markets metal components and engineered building systems in the industry.

NCI Building Systems, Inc. (NYSE:NCS) announced it will present at the RBC 2015 Global Industrials Conference which takes place September 9-10, 2015 in Las Vegas, Nevada.
Norman C. Chambers, Chairman, President and Chief Executive Officer, will deliver the Company’s presentation on Thursday, September 10, 2015 at 10:20 a.m. Pacific Time.

Nutraceutical International Corporation (NASDAQ:NUTR) ended the last trading day at $24.24. Company weekly volatility is calculated as 3.02% and price to cash ratio as 0.69. Nutraceutical International Corporation (NASDAQ:NUTR) showed a weekly performance of 8.85%.

Nutraceutical International Corporation (Nutraceutical), is an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold through domestic health and natural food stores. The Company manufactures and sells nutritional supplements and other natural products under numerous brands including Solaray, KAL, Nature’s Life, LifeTime, Natural Balance, bioAllers, Herbs for Kids, NaturalCare, Health from the Sun, Life-flo, Organix South, Pioneer and Monarch Nutraceuticals.

On 31 August, PMC-Sierra Inc. (NASDAQ:PMCS) shares fell -0.63% and was closed at $6.29. PMCS EPS growth in last 5 year was 71.80%. PMC-Sierra Inc. (NASDAQ:PMCS) year to date (YTD) performance is -31.33%.

PMC-Sierra, Inc. (PMC) is a semiconductor and software solution innovator transforming networks that connect, move, and store Big Data. The Company designs, develops, markets and supports semiconductor, embedded software, and board level solutions. The Company has approximately 700 different semiconductor devices that are sold to equipment and design manufacturers, who in turn supply their equipment principally to enterprises, Cloud Data Centers and carriers worldwide.

PMC-Sierra, Inc. (NASDAQ:PMCS) announced that its Switchtec™ PSX PCIe Storage Switches will be an industry partner solution in the Intel® Rack Scale Architecture (Intel® RSA) demonstration at the Intel Developer Forum, “Your Datacenter and Software Defined Infrastructure” zone, August 18-20, 2015, at the Moscone West Convention Center, San Francisco.

Emmis Communications Corp. (NASDAQ:EMMS) shares advanced 12.50% in last trading session and ended the day at $1.26. EMMS Gross Margin is 22.40% and its has a return on assets of -23.70%. Emmis Communications Corp. (NASDAQ:EMMS) quarterly performance is 4.13%.

Emmis Communications Corporation is a diversified media company, focused on radio broadcasting. The Company owns 18 frequency modulation (FM) and 3 amplitude modulation (AM) radio stations in New York, Los Angeles, St. Louis, Austin, Indianapolis, and Terre Haute, Indiana, and operates two additional stations in New York (one FM and one AM) pursuant to a local marketing agreement (LMA) whereby the Company provides the programming for these stations and sells all advertising within that programming.

On August 21 2015, Emmis Communications Corporation (NASDAQ:EMMS) received a letter from Nasdaq notifying the Company that its Series A Non-Cumulative Convertible Preferred Stock (listed on the Nasdaq Global Select Market under the symbol “EMMSP”) (“Preferred Stock”) no longer complies with the requirement under Nasdaq Listing Rule 5460(a)(2) to maintain a minimum Market Value of Publicly Held Shares (as such terms are defined under the Nasdaq Listing Rules, “MVPHS”) of $1 Millio

Aeterna Zentaris Inc. (NASDAQ:AEZS) caters to the Healthcare space. Its weekly performance is 4.31%. On the last day of trading company shares ended up $0.09. Aeterna Zentaris Inc. (NASDAQ:AEZS) distance from 50-day simple moving average (SMA50) is -54.40%.

Aeterna Zentaris Inc. is a Canada based biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company currently has three wholly owned direct and indirect subsidiaries, Aeterna Zentaris GmbH (AEZS Germany), Zentaris IVF GmbH, a wholly owned subsidiary of AEZS Germany, and Aeterna Zentaris, Inc.

Zacks upgraded shares of AEterna Zentaris (NASDAQ:AEZS) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, MarketBeat reports. They currently have $0.25 target price on the biopharmaceutical company’s stock.